Posted on 1 4 月, 2024 by: jcn Embrace Wellness with Your Cherished Canine at Hyatt Regency Hakone Resort & Spa TOKYO, Apr 1, 2024 – … More ...
Posted on 1 4 月, 2024 by: jcn Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease to the U.S. FDA TOKYO and CAMBRIDGE, Mass … More ...